Richard Petty
Psychiatry · Loganville, GANPI 1730334079
Payments from drug & device makers
$2,850,710in general payments, 2019–2025
Across 3,105 payments — averaging $918.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$969K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$520K
- Vanda Pharmaceuticals Inc.$500K
- Axsome Therapeutics, Inc.$471K
- Alkermes, Inc.$178K
- E.r. Squibb & Sons, L.L.C.$157K
- plus $55K from 4 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 974 | $969,415 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 519 | $520,459 |
| Vanda Pharmaceuticals Inc. | 595 | $500,496 |
| Axsome Therapeutics, Inc. | 555 | $470,504 |
| Alkermes, Inc. | 183 | $177,975 |
| E.r. Squibb & Sons, L.L.C. | 171 | $156,611 |
| Sunovion Pharmaceuticals Inc. | 52 | $28,432 |
| Takeda Pharmaceuticals U.S.A., Inc. | 43 | $23,788 |
| Johnson & Johnson | 12 | $3,007 |
| Boehringer Ingelheim | 1 | $22 |
How this compares
$2,850,710 in reported general payments places this provider in the 95th percentile of 900 psychiatry providers in Georgia.
Other psychiatry in Loganville
- Robert RiesenbergAtlanta$51.1M
- Saundra Maass-RobinsonAtlanta$11.1M
- David PurselleAtlanta$7.4M
- Maria JohnsonDecatur$5.4M
- Bethany DavisAtlanta$4.4M
- Michael BanovMarietta$4.2M
- Michael MobleySavannah$2.9M
- Felipe SuplicyRome$2.3M
- Angelo SambunarisAlpharetta$2M
- Ann GrooverCalhoun$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.